Heart-Saving hope: melatonin and vitamin d tested in breast cancer patients
NCT ID NCT07349459
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether melatonin or vitamin D can help prevent heart damage in breast cancer patients receiving the chemotherapy drug doxorubicin. About 90 women will be randomly assigned to take melatonin, vitamin D, or a placebo alongside their cancer treatment. The goal is to see if these supplements reduce the risk of heart problems caused by doxorubicin.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER PATIENTS DIAGNOSED are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tanta University
Tanta, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could vitamin d predict cervical cancer treatment success?
- Can melatonin help ICU patients sleep better?
- Sleep hormone gel boosts gum disease therapy?
- Melatonin's hidden role in blood sugar revealed in new study
- Could a sleep aid beat a nerve pain drug for surgery recovery?
- Hospital lights may fix sleep in frail seniors